Physician profile
Jason R Bailey
NPI 1407059280
$2,210.66
in general payments reported to CMS, 2019-2025
17 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $218 · 2021: $556 · 2022: $404 · 2023: $222 · 2024: $158 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $476.10 | 2022-2025 | Matrixmandible, Matrixneuro, Matrixwave |
| Zimmer Biomet Holdings, INC. | $461.99 | 2020-2023 | |
| Musculoskeletal Transplant Foundation INC. | $278.16 | 2020-2023 | |
| Stryker Corporation | $216.86 | 2020-2022 | |
| Allergan, INC. | $162.63 | 2020-2022 | |
| Wound Management Technologies, INC | $130.98 | 2019 | |
| Tei Medical INC. | $121.50 | 2019 | |
| Mentor Worldwide LLC | $117.27 | 2021 | |
| Heron Therapeutics, INC. | $45.00 | 2019 | |
| Avita Medical Americas, LLC | $38.51 | 2025 | Recell, Cohealyx, Permeaderm |
| Innovation Technologies INC | $36.80 | 2022-2025 | Irrisept |
| Medinc of Texas | $28.51 | 2025 | |
| Integra Lifesciences Corporation | $25.05 | 2019 | |
| Polynovo North America LLC | $23.73 | 2025 | Novosorb Btm |
| Glaxosmithkline, LLC. | $19.26 | 2025 | Benlysta |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $15.59 | 2020 | |
| Baxter Healthcare | $12.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.